UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (Date of earliest event reported): June 15, 2020
Valaris plc
(Exact name of registrant as specified in its charter)
|
| | |
England and Wales | 1-8097 | 98-0635229 |
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
110 Cannon Street
London, England EC4N6EU
(Address of Principal Executive Offices and Zip Code)
Registrant’s telephone number, including area code: 44 (0) 20 7659 4660
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
| |
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
| |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
| |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
| |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
|
| | | |
Title of each class | Ticker Symbol(s) | | Name of each exchange on which registered |
Class A ordinary shares, U.S. $0.40 par value | VAL | | New York Stock Exchange |
4.70% Senior Notes due 2021 | VAL21 | | New York Stock Exchange |
4.875% Senior Note due 2022 | VAL/22 | | New York Stock Exchange |
4.50% Senior Notes due 2024 | VAL24 | | New York Stock Exchange |
4.75% Senior Note due 2024 | VAL/24 | | New York Stock Exchange |
8.00% Senior Notes due 2024 | VAL24A | | New York Stock Exchange |
5.20% Senior Notes due 2025 | VAL25A | | New York Stock Exchange |
7.375% Senior Note due 2025 | VAL/25 | | New York Stock Exchange |
7.75% Senior Notes due 2026 | VAL26 | | New York Stock Exchange |
5.4% Senior Note due 2042 | VAL/42 | | New York Stock Exchange |
5.75% Senior Notes due 2044 | VAL44 | | New York Stock Exchange |
5.85% Senior Note due 2044 | VAL/44 | | New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined by Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2). |
| |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ |
TABLE OF CONTENTS
|
| |
| |
INFORMATION TO BE INCLUDED IN THE REPORT | |
| |
| |
Item 5.07 Submission of Matters to a Vote of Security Holders
(a) The Company held its 2020 Annual General Meeting in London, England on June 15, 2020.
(b) As previously announced, Keith O. Rattie and Carl G. Trowell's service on the Board of Directors of the Company ended on June 15, 2020.
(c) There were 198,419,838 shares entitled to vote at the meeting based on the March 23, 2020 record date, of which 131,256,529 shares, or 66.15%, were present and voting in person or by proxy. The following matters, detailed descriptions of which are contained in the 2020 Proxy Statement, were voted on at the meeting:
|
|
(1) To re-elect Directors to serve until the 2021 Annual General Meeting of Shareholders: |
|
| | | | | | |
a. William E. Albrecht | | | | | |
| | | | | | Broker |
Votes For | | Votes Against | | Votes Abstain | | Non-Votes |
87,590,525 | | 8,037,355 | | 3,365,142 | | 32,263,507 |
|
| | | | | | |
b. Frederick Arnold | | | | | |
| | | | | | Broker |
Votes For | | Votes Against | | Votes Abstain | | Non-Votes |
89,182,428 | | 6,445,006 | | 3,365,588 | | 32,263,507 |
|
| | | | | | |
c. Thomas P. Burke | | | | | |
| | | | | | Broker |
Votes For | | Votes Against | | Votes Abstain | | Non-Votes |
89,134,644 | | 1,348,214 | | 8,510,164 | | 32,263,507 |
|
| | | | | | |
d. Mary E. Francis CBE | | | | | |
| | | | | | Broker |
Votes For | | Votes Against | | Votes Abstain | | Non-Votes |
88,819,834 | | 6,841,309 | | 3,331,879 | | 32,263,507 |
|
| | | | | | |
e. Georges J. Lambert | | | | | |
| | | | | | Broker |
Votes For | | Votes Against | | Votes Abstain | | Non-Votes |
89,153,745 | | 6,447,461 | | 3,391,816 | | 32,263,507 |
|
| | | | | | |
f. Suzanne P. Nimocks | | | | | |
| | | | | | Broker |
Votes For | | Votes Against | | Votes Abstain | | Non-Votes |
89,087,221 | | 6,519,057 | | 3,386,744 | | 32,263,507 |
|
| | | | | | |
g. Thierry Pilenko | | | | | |
| | | | | | Broker |
Votes For | | Votes Against | | Votes Abstain | | Non-Votes |
88,846,352 | | 6,756,668 | | 3,390,002 | | 32,263,507 |
|
| | | | | | |
h. Paul E. Rowsey, III | | | | | |
| | | | | | Broker |
Votes For | | Votes Against | | Votes Abstain | | Non-Votes |
88,081,839 | | 7,608,589 | | 3,302,594 | | 32,263,507 |
|
| | | | | | |
i. Charles L. Szews | | | | | |
| | | | | | Broker |
Votes For | | Votes Against | | Votes Abstain | | Non-Votes |
89,130,910 | | 6,467,492 | | 3,394,620 | | 32,263,507 |
|
| | | | | | |
j. Adam Weitzman | | | | | |
| | | | | | Broker |
Votes For | | Votes Against | | Votes Abstain | | Non-Votes |
89,101,584 | | 1,342,243 | | 8,549,195 | | 32,263,507 |
|
|
(2) To ratify the Audit Committee's appointment of KPMG LLP (U.S.) as our U.S. independent registered public accounting firm for the fiscal year ending 31 December 2020: |
|
| | | | | | |
| | | | | | Broker |
Votes For | | Votes Against | | Votes Abstain | | Non-Votes |
125,754,000 | | 2,147,241 | | 3,355,288 | | N/A |
|
|
(3) To appoint KPMG LLP (U.K.) as our U.K. statutory auditors under the U.K. Companies Act 2006 (to hold office from the conclusion of the 2020 Annual General Meeting of Shareholders until the conclusion of the next Annual General Meeting of Shareholders at which accounts are laid before the Company): |
|
| | | | | | |
| | | | | | Broker |
Votes For | | Votes Against | | Votes Abstain | | Non-Votes |
125,756,600 | | 2,137,652 | | 3,362,277 | | N/A |
|
|
(4) To authorise the Audit Committee to determine our U.K. statutory auditors' remuneration:
|
|
| | | | | | |
| | | | | | Broker |
Votes For | | Votes Against | | Votes Abstain | | Non-Votes |
125,739,552 | | 2,054,618 | | 3,462,359 | | N/A |
|
| | | | |
(5) To approve an amendment to the 2018 Long-Term Incentive Plan |
|
| | | | | | |
| | | | | | Broker |
Votes For | | Votes Against | | Votes Abstain | | Non-Votes |
88,082,007 | | 7,592,306 | | 3,318,709 | | 32,263,507 |
|
| | | | |
(6) To approve the Directors' Remuneration Policy |
|
| | | | | | |
| | | | | | Broker |
Votes For | | Votes Against | | Votes Abstain | | Non-Votes |
87,459,851 | | 8,253,954 | | 3,279,217 | | 32,263,507 |
|
|
(7) A non-binding advisory vote to approve the Directors' Remuneration Report for the year ended 31 December 2019: |
|
| | | | | | |
| | | | | | Broker |
Votes For | | Votes Against | | Votes Abstain | | Non-Votes |
89,400,129 | | 6,098,282 | | 3,494,611 | | 32,263,507 |
|
|
(8) A non-binding advisory vote to approve the compensation of our named executive officers: |
|
| | | | | | |
| | | | | | Broker |
Votes For | | Votes Against | | Votes Abstain | | Non-Votes |
89,428,294 | | 6,054,534 | | 3,510,194 | | 32,263,507 |
|
|
(9) A non-binding advisory vote to approve the reports of the auditors and the directors and the U.K. statutory accounts for the year ended 31 December 2019: |
|
| | | | | | |
| | | | | | Broker |
Votes For | | Votes Against | | Votes Abstain | | Non-Votes |
125,116,993 | | 2,529,588 | | 3,609,948 | | N/A |
|
|
(10) To authorise the Board of Director to allot shares, the full text of which can be found in "Resolution 10" of the proxy statement: |
|
| | | | | | |
| | | | | | Broker |
Votes For | | Votes Against | | Votes Abstain | | Non-Votes |
112,783,688 | | 14,509,063 | | 3,963,778 | | N/A |
|
|
(11) To approve the general disapplication of pre-emption rights, the full text of which can be found in “Resolution 11” of the proxy statement: |
|
| | | | | | |
| | | | | | Broker |
Votes For | | Votes Against | | Votes Abstain | | Non-Votes |
115,214,455 | | 11,713,569 | | 4,328,505 | | N/A |
|
|
(12) To approve the disapplication of pre-emption rights in connection with an acquisition or specified capital investment, the full text of which can be found in “Resolution 12” of the proxy statement: |
|
| | | | | | |
| | | | | | Broker |
Votes For | | Votes Against | | Votes Abstain | | Non-Votes |
115,218,798 | | 11,693,296 | | 4,344,435 | | N/A |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
| |
| Valaris plc |
| |
Date: June 15, 2020 | /s/ Michael T. McGuinty |
| Michael T. McGuinty |
| Senior Vice President and General Counsel |